Biostar Pharmaceuticals Shares Outstanding 2009-2017 | BSPM

Current and historical number of shares outstanding for Biostar Pharmaceuticals (BSPM) from 2009 to 2017. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Biostar Pharmaceuticals Annual Shares Outstanding
(Millions of US $)
2016 $2
2015 $2
2014 $2
2013 $2
2012 $1
2011 $1
2010 $1
2009 $1
2008 $1
Biostar Pharmaceuticals Quarterly Shares Outstanding
(Millions of US $)
Q3 2017 $3
Q2 2017 $3
Q1 2017 $3
Q4 2016 $2
Q3 2016 $2
Q2 2016 $2
Q1 2016 $2
Q4 2015 $2
Q3 2015 $2
Q2 2015 $2
Q1 2015 $2
Q4 2014 $2
Q3 2014 $2
Q2 2014 $2
Q1 2014 $2
Q4 2013 $2
Q3 2013 $2
Q2 2013 $2
Q1 2013 $1
Q4 2012 $1
Q3 2012 $1
Q2 2012 $1
Q1 2012 $1
Q4 2011 $2
Q3 2011 $1
Q2 2011 $1
Q1 2011 $1
Q4 2010 $1
Q3 2010 $1
Q2 2010 $1
Q1 2010 $1
Q4 2009 $1
Q3 2009 $1
Q2 2009 $1
Q1 2009 $1
Q4 2008 $0
Q3 2008 $1
Q2 2008 $1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.002B
BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.587B 10.93
Zoetis (ZTS) United States $43.971B 31.91
Grifols (GRFS) Spain $14.203B 18.41
Jazz Pharmaceuticals (JAZZ) Ireland $10.594B 15.59
Neurocrine Biosciences (NBIX) United States $10.480B 0.00
Nektar Therapeutics (NKTR) United States $10.229B 11.96
Sage Therapeutics (SAGE) United States $6.988B 0.00
Ionis Pharmaceuticals (IONS) United States $6.865B 0.00
Catalent (CTLT) United States $5.369B 25.01
United Therapeutics (UTHR) United States $5.345B 6.86
FibroGen (FGEN) United States $5.073B 0.00
Loxo Oncology (LOXO) United States $4.844B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.157B 16.10
Madrigal Pharmaceuticals (MDGL) United States $3.479B 0.00
Endo (ENDP) Ireland $3.402B 4.88
USANA Health Sciences (USNA) United States $3.076B 27.09
Heron Therapeutics (HRTX) United States $3.012B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.905B 0.00
Aerie Pharmaceuticals (AERI) United States $2.901B 0.00
Tilray (TLRY) United States $2.448B 0.00
Spectrum Pharmaceuticals (SPPI) United States $2.425B 0.00
Xencor (XNCR) United States $2.269B 0.00
PTC Therapeutics (PTCT) United States $2.015B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.923B 0.00
Portola Pharmaceuticals (PTLA) United States $1.830B 0.00
Zogenix (ZGNX) United States $1.781B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.685B 20.60
Impax Laboratories (AMRX) United States $1.583B 34.02
Theravance Biopharma (TBPH) Cayman Islands $1.552B 0.00
TESARO (TSRO) United States $1.491B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.435B 0.00
Corcept Therapeutics (CORT) United States $1.424B 21.91
ImmunoGen (IMGN) United States $1.362B 0.00
Esperion Therapeutics (ESPR) United States $1.220B 0.00
TherapeuticsMD (TXMD) United States $1.194B 0.00
Endocyte (ECYT) United States $1.106B 0.00
Karyopharm Therapeutics (KPTI) United States $1.091B 0.00
Tricida (TCDA) United States $0.989B 0.00
Radius Health (RDUS) United States $0.952B 0.00
Flexion Therapeutics (FLXN) United States $0.906B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.781B 0.00
OptiNose (OPTN) United States $0.741B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.722B 0.00
CASI Pharmaceuticals (CASI) United States $0.699B 0.00
Dova Pharmaceuticals (DOVA) United States $0.655B 0.00
GlycoMimetics (GLYC) United States $0.630B 0.00
Siga Technologies (SIGA) United States $0.626B 0.00
ChemoCentryx (CCXI) United States $0.623B 37.26
ArQule (ARQL) United States $0.618B 0.00
Collegium Pharmaceutical (COLL) United States $0.611B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.592B 0.00
Aclaris Therapeutics (ACRS) United States $0.530B 0.00
Majesco Entertainment (COOL) United States $0.518B 0.00
Lannett Co Inc (LCI) United States $0.515B 4.74
Odonate Therapeutics (ODT) United States $0.493B 0.00
Translate Bio (TBIO) United States $0.463B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.461B 0.00
Depomed (DEPO) United States $0.459B 0.00
Akebia Therapeutics (AKBA) United States $0.446B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.446B 0.00
Forty Seven (FTSV) United States $0.443B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.436B 0.00
Xeris Pharmaceuticals (XERS) United States $0.418B 0.00
Dermira (DERM) United States $0.408B 0.00
ElectroCore (ECOR) United States $0.397B 0.00
Aquestive Therapeutics (AQST) United States $0.396B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.391B 26.67
Verrica Pharmaceuticals (VRCA) United States $0.385B 0.00
Concert Pharmaceuticals (CNCE) United States $0.384B 0.00
Mast Therapeutics (SVRA) United States $0.382B 0.00
Minerva Neurosciences (NERV) United States $0.328B 0.00
Neon Therapeutics (NTGN) United States $0.325B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.302B 0.00
Opexa Therapeutics (ACER) United States $0.282B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.282B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.278B 0.00
Zafgen (ZFGN) United States $0.267B 0.00
Achaogen (AKAO) United States $0.263B 0.00
Jounce Therapeutics (JNCE) United States $0.262B 0.00
Aratana Therapeutics (PETX) United States $0.245B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.242B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.241B 0.00
Tyme Technologies (TYME) United States $0.235B 0.00
Ocular Therapeutix (OCUL) United States $0.234B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.217B 0.00
DURECT (DRRX) United States $0.214B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.199B 0.00
Adherex Technologies (FENC) United States $0.196B 0.00
Ardelyx (ARDX) United States $0.193B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.188B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.183B 0.00
Neos Therapeutics (NEOS) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Calithera Biosciences (CALA) United States $0.166B 0.00
Cardiome Pharma (CORV) Canada $0.165B 0.00
Immune Design (IMDZ) United States $0.165B 0.00
Galectin Therapeutics (GALT) United States $0.164B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.163B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
ContraFect (CFRX) United States $0.157B 0.00
Melinta Therapeutics (MLNT) United States $0.154B 0.00
ProNAi Therapeutics (SRRA) Canada $0.152B 0.00
KalVista Pharmaceuticals (KALV) United States $0.141B 0.00
Forward Pharma (FWP) Denmark $0.136B 0.00
MEI Pharma (MEIP) United States $0.133B 0.00
Molecular Templates (MTEM) United States $0.132B 0.00
Juniper Pharmaceuticals (JNP) United States $0.130B 0.00
Redhill Biopharma (RDHL) Israel $0.129B 0.00
SteadyMed (STDY) Israel $0.126B 0.00
Recro Pharma (REPH) United States $0.122B 0.00
Iterum Therapeutics (ITRM) Ireland $0.120B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.115B 0.00
CTI BioPharma (CTIC) United States $0.114B 0.00
Rafael Holdings (RFL) United States $0.114B 0.00
Infinity Pharmaceuticals (INFI) United States $0.113B 0.00
Otonomy (OTIC) United States $0.099B 0.00
Nivalis Therapeutics (ALPN) United States $0.097B 0.00
Affimed (AFMD) Germany $0.097B 0.00
BioLineRx (BLRX) Israel $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.083B 0.00
KemPharm (KMPH) United States $0.077B 0.00
Natural Alternatives (NAII) United States $0.074B 9.56
Trillium Therapeutics (TRIL) Canada $0.070B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.070B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.067B 0.00
Novan (NOVN) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.063B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.051B 0.00
Capnia (SLNO) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.050B 26.20
Genocea Biosciences (GNCA) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.046B 38.38
Heat Biologics (HTBX) United States $0.042B 0.00
Avenue Therapeutics (ATXI) United States $0.042B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.041B 0.00
Xenetic Biosciences (XBIO) United States $0.038B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.96
Onconova Therapeutics (ONTX) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.034B 0.00
Lipocine (LPCN) United States $0.033B 0.00
Biomerica (BMRA) United States $0.033B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.030B 0.00
HANCOCK JAFFE (HJLI) United States $0.026B 0.00
Shineco (TYHT) China $0.026B 2.25
XTL Biopharmaceuticals (XTLB) Israel $0.024B 0.00
NanoViricides (NNVC) United States $0.024B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Aradigm (ARDM) United States $0.021B 0.00
Regulus Therapeutics (RGLS) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Midatech Pharma (MTP) United Kingdom $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
ESSA Pharma (EPIX) Canada $0.018B 0.00
Egalet (EGLT) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Skyline Medical (AIPT) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Intellipharmaceutics (IPCI) Canada $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
India Globalization Capital (IGC) United States $0.011B 0.00
PharmAthene (ALT) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.009B 0.00
Pain Therapeutics (PTIE) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
RXi Pharmaceuticals (RXII) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00